Update on the use of pramipexole in the treatment of Parkinson's disease.

abstract：BACKGROUND:Contemporary literature suggests that medical education might adversely affect students' mental health. Alfaisal University in Riyadh, Saudi Arabia is a developing institution; hence, there has been a concern regarding the mental well-being of the students. OBJECTIVES:This study was designed to assess the t...

journal_title：Neuropsychiatric disease and treatment

authors： Kulsoom B,Afsar NA

更新日期：2015-07-16 00:00:00

abstract：Purpose:Cardiovascular and metabolic adverse events are costly to treat, and their incidence is increased amongst people with schizophrenia, with different rates observed for second-generation antipsychotics. To inform treatment choice, this study sought to estimate the lifetime costs associated with antipsychotic choi...

journal_title：Neuropsychiatric disease and treatment

authors： Kearns B,Cooper K,Cantrell A,Thomas C

更新日期：2021-01-20 00:00:00

abstract：:Bipolar disorder (BD) is a debilitating and difficult-to-treat psychiatric disease that presents a serious burden to patients' lives as well as health care systems around the world. The essential diagnostic criterion for BD is episodes of mania or hypomania; however, the patients report that the majority of their time...

journal_title：Neuropsychiatric disease and treatment

authors： Franklin R,Zorowitz S,Corse AK,Widge AS,Deckersbach T

更新日期：2015-08-19 00:00:00

abstract：BACKGROUND:Progressive cognitive decline develops in a nontrivial minority of stroke survivors. Although commonly used to identify cognitive decline in older stroke survivors, the usefulness of the Mini-Mental State Examination (MMSE) as a screening tool for post-stroke cognitive decline across a wider range of ages is...

journal_title：Neuropsychiatric disease and treatment

authors： Arciniegas DB,Kellermeyer GF,Bonifer NM,Anderson-Salvi KM,Anderson CA

更新日期：2011-01-01 00:00:00

abstract：:Obsessive-compulsive disorder (OCD) is a chronic anxiety disorder. While medication and psychotherapy advances have been very helpful to patients, many patients do not respond adequately to initial trials of serotonergic medication or cognitive-behavioral therapy (CBT) and require multiple treatment trials or combinat...

journal_title：Neuropsychiatric disease and treatment

authors： Walsh KH,McDougle CJ

更新日期：2011-01-01 00:00:00

abstract：:A series of cases are reported in which patients on aripiprazole have developed akathisia, although the literature states that the rate is negligible. ...

journal_title：Neuropsychiatric disease and treatment

authors： Basu R,Brar JS

更新日期：2006-06-01 00:00:00

abstract：BACKGROUND:The majority of previous neuroimaging studies have demonstrated both structural and functional abnormalities in obstructive sleep apnea (OSA). However, few studies have focused on the regional intensity of spontaneous fluctuations during the resting state and the relationship between the abnormal properties ...

journal_title：Neuropsychiatric disease and treatment

authors： Li HJ,Dai XJ,Gong HH,Nie X,Zhang W,Peng DC

更新日期：2015-01-23 00:00:00

abstract：BACKGROUND:In recent years, great attention has been given to the presence of psychological problems and psychiatric comorbidity that are also present in children affected by primary headaches. The relationship between pain and attachment has been identified, and it may be that pain perception may change in relation wi...

journal_title：Neuropsychiatric disease and treatment

authors： Esposito M,Parisi L,Gallai B,Marotta R,Di Dona A,Lavano SM,Roccella M,Carotenuto M

更新日期：2013-01-01 00:00:00

abstract：:Cognitive impairment is closely related to real-life functioning in patients with schizophrenia. The aim of the present study was to evaluate the effects of adjunctive treatment with donepezil on cognition in patients with chronic schizophrenia. This was a 12-week, double-blind, randomized, placebo-controlled study of...

journal_title：Neuropsychiatric disease and treatment

authors： Zhu W,Zhang Z,Qi J,Liu F,Chen J,Zhao J,Guo X

更新日期：2014-07-14 00:00:00

abstract：Purpose:The purpose of this study was to examine alexithymia among restless legs syndrome (RLS) patients, compare with healthy controls, and argue the clinical inferences of this relationship. We searched for anxiety and depression and their clinical outcomes among patients and searched whether the results are similar ...

journal_title：Neuropsychiatric disease and treatment

authors： Yilmaz O,Şengül Y,Şengül HS,Parlakkaya FB,Öztürk A

更新日期：2018-08-29 00:00:00

abstract：:Autoimmune encephalitis is a rare and newly described group of diseases involving autoantibodies directed against synaptic and neuronal cell surface antigens. It comprises a wide range of neuropsychiatric symptoms. Sensitive and specific diagnostic tests such as cell-based assay are primordial for the detection of neu...

journal_title：Neuropsychiatric disease and treatment

authors： Bost C,Pascual O,Honnorat J

更新日期：2016-10-27 00:00:00

abstract：Background:The phospholipase A2 Group 6 (PLA2G6, also known as PLA2, PARK14, and iPLA2) gene encodes a group VIA calcium-independent phospholipase A2. Genetic polymorphism of PLA2G6 has been indicated to be involved in conferring susceptibility for Parkinson's disease (PD), whereas conclusive results have not been obta...

journal_title：Neuropsychiatric disease and treatment

authors： Liu H,Yao Y,Liu H,Peng Y,Ren J,Wu X,Mao R,Zhao J,Zhu Y,Niu Z,Yang T,Sun X,Jiang P,Zhang C,Fang Y

更新日期：2020-07-23 00:00:00

abstract：BACKGROUND:Recently, the sigma-1 receptor has been shown to play a significant role in the neural transmission of mood by regulating N-methyl-D-aspartate receptors. Additionally, the sigma-1 receptor has been reported to influence cognitive functions including learning and memory. In this study, we measured plasma sigm...

journal_title：Neuropsychiatric disease and treatment

authors： Shimizu H,Takebayashi M,Tani M,Tanaka H,Yamagata B,Kurosawa K,Yamada H,Hachisu M,Hisaoka-Nakashima K,Okada-Tsuchioka M,Mimura M,Iwanami A

更新日期：2013-01-01 00:00:00

abstract：:Abnormal prion proteins are responsible for several fatal neurodegenerative diseases in humans and in animals, including Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker disease, and fatal familial insomnia. Genetics is important in prion diseases, but in the most cases, cause of diseases remained unkno...

journal_title：Neuropsychiatric disease and treatment

authors： Bagyinszky E,Giau VV,Youn YC,An SSA,Kim S

更新日期：2018-08-14 00:00:00

abstract：:Traumatic brain injury (TBI) is a well recognized public health problem worldwide. TBI has previously been considered as a rare cause of hypopituitarism, but an increased prevalence of neuroendocrine dysfunction in patients with TBI has been reported during the last 15 years in most of the retrospective and prospectiv...

journal_title：Neuropsychiatric disease and treatment

authors： Tanriverdi F,Kelestimur F

更新日期：2015-07-27 00:00:00

abstract：:Whipple disease (WD) is a rare systemic disorder caused by the bacteria Tropheryma whipplei. In its classic form, it manifests with gastrointestinal problems including diarrhea, abdominal pain, and weight loss. However, various other systems can be affected, including the central nervous system (CNS). Even more rarely...

journal_title：Neuropsychiatric disease and treatment

authors： Peregrin J,Malikova H

更新日期：2015-09-25 00:00:00

abstract：:The essential features of bipolar affective disorder involve the cyclical occurrence of high (manic or hypomanic episodes) and low mood states. Depressive episodes in both bipolar I and II disorder are more numerous and last for longer duration than either manic or hypomanic episodes. In addition depressive episodes a...

journal_title：Neuropsychiatric disease and treatment

authors： Gajwani P,Muzina DJ,Kemp DE,Gao K,Calabrese JR

更新日期：2007-12-01 00:00:00

abstract：:Multiple Sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system, and both T and B cells are involved in its pathogenesis. The vast majority of disease-modifying drugs used for MS act on the inflammatory component of the disease and are approved for use in relapsing-remitting (RR)...

journal_title：Neuropsychiatric disease and treatment

authors： Frau J,Coghe G,Lorefice L,Fenu G,Cocco E

更新日期：2018-04-23 00:00:00

abstract：:Schizophrenia is a chronic syndrome involving different clinical dimensions, and causes significant disability with a negative impact on the quality of life of patients and their caregivers. Current guidelines for the treatment of schizophrenia focus on maximizing a patient's adaptive functioning and quality of life i...

journal_title：Neuropsychiatric disease and treatment

authors： Pietrini F,Albert U,Ballerini A,Calò P,Maina G,Pinna F,Vaggi M,Boggian I,Fontana M,Moro C,Carpiniello B

更新日期：2019-04-30 00:00:00

abstract：Purpose:Entropy analysis of resting-state functional magnetic resonance imaging (R-fMRI) has recently been adopted to characterize brain temporal dynamics in some neuropsychological or psychiatric diseases. Thalamus-related dysfunction might be a potential trait marker of major depressive disorder (MDD), but the abnorm...

journal_title：Neuropsychiatric disease and treatment

authors： Xue SW,Wang D,Tan Z,Wang Y,Lian Z,Sun Y,Hu X,Wang X,Zhou X

更新日期：2019-09-11 00:00:00

abstract：OBJECTIVE:The abuse of illegal substances by youths in Taiwan has become a major public health issue. This study explores the outcomes (relapse rate and academic or social status) of a family-oriented therapy program conducted for substance-using youths who were referred by a judge to participate in it. METHODS:The pr...

journal_title：Neuropsychiatric disease and treatment

authors： Wang LJ,Lu SF,Chong MY,Chou WJ,Hsieh YL,Tsai TN,Chen C,Lee YH

更新日期：2016-03-30 00:00:00

abstract：Background:Mental disorders affect about one-third of the human population, are typically chronic and significantly decrease the quality of life. Presently, the treatment of mental illnesses is far from adequate with a substantial proportion of the patients being pharmacoresistant and suffering from relapses. One of t...

journal_title：Neuropsychiatric disease and treatment

authors： Latalova K,Sery O,Hosakova K,Hosak L

更新日期：2020-05-06 00:00:00

abstract：Purpose:To investigate the current clinical practice of Japanese physicians in the diagnosis and management of major depression (major depressive disorder [MDD]). Patients and methods:Japanese physicians specializing in psychiatry or psychosomatic medicine in the medical database of Nihon Ultmarc Inc. (Chuo-Ku, Tokyo,...

journal_title：Neuropsychiatric disease and treatment

authors： Hori H,Yamato K

更新日期：2019-10-01 00:00:00

abstract：OBJECTIVE:To describe antidepressant (AD) use in the treatment of major depressive disorder during a period of economic crisis. PATIENTS AND METHODS:This was a retrospective, observational study using population-based databases. Two periods were considered: 1) 2008-2009, precrisis, and 2) 2012-2013, economic crisis. C...

journal_title：Neuropsychiatric disease and treatment

authors： Sicras-Mainar A,Navarro-Artieda R

更新日期：2015-12-30 00:00:00

abstract：BACKGROUND:Relapse is common in schizophrenia, and seriously impacts patients' quality of life and social functioning. Many factors have been identified that may potentially increase the risk of relapse. This study was designed to investigate the relapse rate in the year following hospital discharge among Chinese patie...

journal_title：Neuropsychiatric disease and treatment

authors： Xiao J,Mi W,Li L,Shi Y,Zhang H

更新日期：2015-05-08 00:00:00

abstract：Purpose:Nightmares are associated with many negative health outcomes; however, little is known about the characteristics of nightmares in heroin-dependent patients (HDPs). This study examined the prevalence and correlates of frequent nightmares (FNs) and their association with functional impairment in Chinese patients ...

journal_title：Neuropsychiatric disease and treatment

authors： Zhong BL,Xu YM,Xie WX,Lu J

更新日期：2019-07-18 00:00:00

abstract：Purpose:Mood disorders are recurrent chronic disorders with fluctuating mood states and energy, and misdiagnosis is common when based solely on clinical interviews because of overlapping symptoms. Because misdiagnosis may lead to inappropriate treatment and poor prognosis, finding an easily implemented objective tool f...

journal_title：Neuropsychiatric disease and treatment

authors： Chen S,Jiang H,Xu Z,Zhao J,Wang M,Lu Y,Li J,Sun F,Yuan Y

更新日期：2019-01-15 00:00:00

abstract：PURPOSE:To investigate the perception of dignity among patients hospitalized in a psychiatric setting using the Patient Dignity Inventory (PDI), which had been first validated in oncologic field among terminally ill patients. PATIENTS AND METHODS:After having modified two items, we administered the Italian version of ...

journal_title：Neuropsychiatric disease and treatment

authors： Di Lorenzo R,Cabri G,Carretti E,Galli G,Giambalvo N,Rioli G,Saraceni S,Spiga G,Del Giovane C,Ferri P

更新日期：2017-01-23 00:00:00

abstract：:An 87-year-old woman had both Lewy body dementia and normal pressure hydrocephalus simultaneously. One should not automatically exclude the possibility of normal pressure hydrocephalus simply because another neurodegenerative disorder is present, especially if the second disorder masks typical symptoms of normal press...

journal_title：Neuropsychiatric disease and treatment

authors： Alisky J

更新日期：2008-02-01 00:00:00

abstract：:To date, the role of metabotropic glutamate receptor 3 (GRM3) rs274622, rs1468412, rs917071, rs6465084, and rs2299225 polymorphisms in schizophrenia remains controversial. To provide a clearer picture for the effect of the five most studied GRM3 polymorphisms on risk of schizophrenia, this meta-analysis with eligible ...

journal_title：Neuropsychiatric disease and treatment

authors： Yang X,Wang G,Wang Y,Yue X

更新日期：2015-03-25 00:00:00